UK/EU Data Protection Compliance in Clinical Trials: A Guide for Life Sciences, Biotech, and Pharma Industries

Introduction

In the highly regulated world of clinical trials, successfully managing UK/EU clinical trial data while ensuring compliance with the UK/EU GDPR is essential for mitigating risks and protecting your business. Establishing and maintaining a strong data protection compliance program is critical for life sciences companies, as noncompliance can result in significant financial and reputational consequences.

Key topics covered will include the roles of parties (controller vs. processor) in clinical trials, and best practices for drafting data protection provisions in informed consent forms and trial agreements.

This webinar will provide practical advice and strategies for ensuring that clinical trials comply with GDPR, reducing potential risks while ensuring smooth business operations.

What You Will Learn

This webinar will guide participants through the complex landscape of GDPR compliance within clinical trials, covering essential topics such as:

• The necessity of GDPR compliance to obtain regulatory approval for clinical trials, commercialize products, and enter into collaborations
• The growing importance of GDPR compliance in IPOs, as underwriters increasingly focus on life sciences companies’ data protection practices during due diligence
• The impact of GDPR compliance on mergers and acquisitions, where data protection issues can create significant deal complications
• The financial and reputational risks of noncompliance, which can include fines up to 4% of annual global revenue, litigation, and restrictions on data processing (including bans and destruction orders)

This pre-recorded webinar will be available to view from Wednesday 4th June 2025

Alternatively, you can gain access to this webinar and 1,700+ others via the MBL Webinar Subscription. Please email webinarsubscription@mblseminars.com for more details.